Streetbeat News

Analyst Ratings

MRVL

Deep-pocketed investors have shown a bullish sentiment towards Marvell Tech (NASDAQ:MRVL), with options activity indicating a focus on a price band between $57.5 and $87.5. The options market's interest, with 69% bullish and 30% bearish sentiment, suggests significant expectations for MRVL's stock movement. Analysts have set a consensus target price of $92.0 for MRVL, with ratings ranging from Overweight to Buy. The stock is currently up 3.93% at $68.72, with potential overbought signals from RSI indicators.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:31 pm

MGM

MGM Resorts International's stock is trading higher following a Buy rating initiation and a $61 price target from Mizuho.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:29 pm

LLAP

Stifel analyst Erik Rasmussen has maintained a Buy rating on Terran Orbital (NYSE:LLAP) and has also maintained a price target of $7 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:26 pm

TH

Stifel analyst Stephen Gengaro has maintained a Buy rating on Target Hospitality (NASDAQ:TH) and kept the price target at $13.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:24 pm

STX

WDC

Western Digital's stock is trading higher, potentially due to Seagate's stock rise following an upgrade from Morgan Stanley. This suggests a sympathetic movement in the sector influenced by analyst ratings.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:22 pm

IR

Stifel analyst Nathan Jones has maintained a Buy rating on Ingersoll Rand (NYSE:IR) and has also maintained a price target of $102 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:21 pm

SYRE

Stifel analyst Alex Thompson has reiterated a Buy rating on Spyre Therapeutics (NASDAQ:SYRE) and increased the price target from $36 to $54, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:18 pm

CLH

Stifel analyst Michael Hoffman has reiterated a Buy rating on Clean Harbors (NYSE:CLH) and increased the price target from $206 to $210.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:17 pm

ZM

Rosenblatt analyst Catharine Trebnick has reiterated a Neutral rating on Zoom Video Communications (ZM) and maintained a $75 price target.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:15 pm

TNDM

Stifel analyst Mathew Blackman upgraded Tandem Diabetes Care (TNDM) from Hold to Buy and increased the price target from $24 to $37.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:15 pm